logo inserm ifrb fondateurCC logoUSPN

Publications of INSERM UMR 1125

Publications of INSERM UMR 1125

Main publications (original papers and review)

 
 

 

 

Main publications (original papers and review)

 

2023

  • Sigaux J, Cavalin C, Lescoat A, El Rharras S, Macchi O, Brillet P-Y, et al. Are cleaning activities a source of exposure to crystalline silica in women with rheumatoid arthritis? A case-control study. RMD Open 2023;9:e003205.
  • Battle of the brains: A comparison of human and ChatGPT health editorials. Boissier MC, Bessis N. Joint Bone Spine. 2023 Jul 11;90(5):105610. doi: 10.1016/j.jbspin.2023.105610.
  • Melbouci D, Haidar Ahmad A, Decker P.Neutrophil extracellular traps (NET): not only antimicrobial but also modulators of innate and adaptive immunities in inflammatory autoimmune diseases. RMD Open. 2023 Aug;9(3):e003104. doi: 10.1136/rmdopen-2023-003104.
  • Jouhault Q, Cherqaoui B, Jobart-Malfait A, Glatigny S, Lauraine M, Hulot A, Morelle G, Hagege B, Ermoza K, El Marjou A, Izac B, Saintpierre B, Letourneur F, Rémy S, Anegon I, Boissier MC, Chiocchia G, Breban M, Araujo LM. Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses. Front Immunol. 2023 Feb 2;13:1072420. doi: 10.3389/fimmu.2022.1072420.
  • Cavalin C, Lescoat A, Sigaux J, Macchi O, Ballerie A, Catinon M, Vincent M, Semerano L, Boissier MC, Rosental PA. Crystalline silica exposure in patients with rheumatoid arthritis and systemic sclerosis: a nationwide cross-sectional survey. Rheumatology (Oxford). 2023 Aug 1;62(8):2707-2715. doi: 10.1093/rheumatology/keac675.

2022

  • Sigaux J, Mathieu S, Nguyen Y, Sanchez P, Letarouilly J-G, Soubrier M, et al. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis. Arthritis Res Ther 2022;24:100.
  • Sigaux J, Bellicha A, Buscail C, Julia C, Flipo R-M, Cantagrel A, et al. Serum Fatty Acid Profiles Are Associated with Disease Activity in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort. Nutrients 2022;14:2947.
  • Haidar Ahmad, A., Melbouci, D. and Decker, P. (2022). Polymorphonuclear Neutrophils in Rheumatoid Arthritis and Systemic Lupus Erythematosus: More Complicated Than Anticipated. Immuno, 2: 85-103.
  • Biton J, Saidenberg-Kermanac’h N, Decker P, Boissier M-C, Semerano L, Sigaux J. The exposome in rheumatoid arthritis. Joint Bone Spine 2022;89:105455.
  • Daien C, Czernichow S, Letarouilly JG, Nguyen Y, Sanchez P, Sigaux J, Beauvais C, Desouches S, Le Puillandre R, Rigalleau V, Rivière P, Romon M, Semerano L, Seror R, Sfedj S, Tournadre A, Vacher D, Wendling D, Flipo RM, Sellam J. Dietary recommendations of the French Society for Rheumatology for patients with chronic inflammatory rheumatic diseases. Joint Bone Spine. 2022 Mar;89(2):105319
  • Abdelkefi I, Saidenberg-Kermanac'h N, Boissier MC, Semerano L, Sigaux J. Crowned dens syndrome. Joint Bone Spine. 2022 Jan;89(1):105288. doi: 10.1016/j.jbspin.2021.105288. Epub 2021 Oct 8. PMID: 34634468.
  • Sanchez P, Letarouilly JG, Nguyen Y, Sigaux J, Barnetche T, Czernichow S, Flipo RM, Sellam J, Daïen C. Efficacy of Probiotics in Rheumatoid Arthritis and Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2022 Jan 14;14(2):354. doi: 10.3390/nu14020354. PMID: 35057535; PMCID: PMC8779560
  • Laborie F, Béal C, Sigaux J. Lumbar facet joint effusion. Joint Bone Spine. 2023 May;90(3):105516. doi: 10.1016/j.jbspin.2022.105516. Epub 2022 Dec 15. PMID: 36529420.
  • Jessen C, Saidenberg-Kermanac'h N, Lanseur B, Sigaux J. Acute unstable thoracic fracture in ankylosing spondylitis. Joint Bone Spine. 2022 Nov;89(6):105424. doi: 10.1016/j.jbspin.2022.105424. Epub 2022 Jun 15. PMID: 35716879.
  • Hassold N, Saidenberg N, Sigaux J, Lacroix M, Cruaud P, Walewski V, Bouchaud O, Méchaï F. Asymptomatic bacteriuria before biotherapy for rheumatic diseases: Shall we treat? Joint Bone Spine. 2022 Mar;89(2):105327. doi: 10.1016/j.jbspin.2021.105327. Epub 2021 Dec 11. PMID: 34906699.
  • Boudjani R, Challal S, Semerano L, Sigaux J. Impact of different types of exercise programs on ankylosing spondylitis: a systematic review and meta-analysis. Disabil Rehabil. 2022 Nov 11:1-12. doi: 10.1080/09638288.2022.2140842. Epub ahead of print. PMID: 36369692.

 

2021

  • Macroautophagy in lymphatic endothelial cells inhibits T cell-mediated autoimmunity. Harlé G, Kowalski C, Dubrot J, Brighouse D, Clavel G, Pick R, Bessis N, Niven J, Scheiermann C, Gannagé M, Hugues S. J. Exp. Med. 2021 Jun 7;218(6):e20201776. doi: 10.1084/jem.20201776.
  • Deoxyribonuclease 1-mediated Clearance of Circulating Chromatin Prevents from Immune Cell Activation and Pro-inflammatory Cytokine Production, a Phenomenon Amplified by Low Trap1 activity: Consequences for Systemic Lupus Erythematosus. Felux J, Erbacher A, Breckler M, Hervé R, Lemeiter D, Mannherz HG, Napirei M, Rammensee HG, Decker P. Front. Immunol. 2021, Mar 4;12:613597.doi: 10.3389/fimmu.2021.613597
  • Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus. Hervier B, Ribon M, Tarantino N, Mussard J, Breckler M, Vieillard V, Amoura Z, Steinle A, Klein R, Kötter I,  Decker P. Front Immunol. 2021 May 3;12:633658. doi: 10.3389/fimmu.2021.63365
  • Mitral valve granulomatosis: A paradoxical reaction complicating etanercept treatment in rheumatoid arthritis. A case report. Ngoufack C, Semerano L, Podglajen I, Bruneval P, Meune C, Valeyre D, Dhote R, Boissier MC, Saidenberg-Kermanac'h N. Joint Bone Spine. 2021 Jul;88(4):105183. doi: 10.1016/j.jbspin.2021MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression. Juge PA, Solomon JJ, van Moorsel CHM, Garofoli R, Lee JS, Louis-Sydney F, Rojas-Serrano J, González-Pérez MI, Mejia M, Buendia-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou KM, Sidiropoulos P, Trachalaki A, van der Vis JJ, Jamnitski A, Grutters JC, Kannengiesser C, Borie R, Kawano-Dourado L, Wemeau-Stervinou L, Flipo RM, Nunes H, Uzunhan Y, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Richez C, Schaeverbeke T, Doyle T, Wolters PJ, Debray MP, Boileau C, Porcher R, Schwartz DA, Crestani B, Dieudé P. Semin Arthritis Rheum. 2021 Oct;51(5):996-1004. doi: 10.1016/j.semarthrit.2021.07.002. Epub 2021 Jul 10.
  • Comparon C, Boubaya M, Sritharan N, Dournon N, Duchemann B, Tine S, Lopez-Sublet M, Mongin M, Giroux-Leprieur B, Bloch-Queyrat C, Sigaux J, Cohen Y, Bohelay G, Caux F, Bihan H, Le Jeune S, Abad S, Levy V, Dhote R; Groupe Immuno Avicenne. A short course of corticosteroids reduces the risk of mechanical ventilation and death in patients with moderate to severe COVID 19 pneumonia: results of a retrospective monocentric cohort. Infect Dis (Lond). 2021 Oct;53(10):779-788. doi: 10.1080/23744235.2021.1928745. Epub 2021 May 22. PMID: 34024240; PMCID: PMC8146301.

2020

  • Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis.Leblond A, Pezet S, Cauvet A, Casas C, Pires Da Silva J, Hervé R, Clavel G, Dumas S, Cohen-Kaminsky S, Bessis N, Semerano L, Lemaire C, Allanore Y, Avouac J.Ann Rheum Dis. 2020 Jul;79(7):891-900. doi: 10.1136/annrheumdis-2020-217377
  • F Santinon, M Batignes, M L Mebrek, J Biton, G Clavel, R Hervé,, D Lemeiter, M Breckler, F Busato, J Tost, M Ziol, MC Boissier, P Decker, ,L Semerano, N Bessis. Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Tregs Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis. Arthritis Rheumatol. 2020 Apr;72(4):576-587. doi: 10.1002/art.41134
  • Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome. Quartuccio L, Semerano L, Benucci M, Boissier MC, De Vita S. Joint Bone Spine. 2020 May;87(3):191-193. doi: 10.1016/j.jbspin.2020.03.011

2019

  • Origins of rheumatoid arthritis. Boissier MC, Biton J, Semerano L, Decker P, Bessis N. Joint Bone Spine. 2020 Jul;87(4):301-306. doi: 10.1016/j.jbspin.2019.11.009. Epub 2019 Dec 5.
  • Extracellular Chromatin Triggers Release of Soluble CEACAM8 Upon Activation of Neutrophils. Ribon M, Mussard J, Semerano L, Singer BB, Decker P. Front Immunol. 2019 Jun 14;10:1346.
  • Corneal and scleral involvement in inflammatory rheumatic disease: Rheumatologists and ophthalmologists exchanging views. Clavel G, Gabison E, Semerano L. Joint Bone Spine. 2019 Nov;86(6):699-705. doi: 10.1016/j.jbspin.2019.01.014.
  • Is fat that bad in rheumatoid arthritis? Clavel G, Sigaux J, Semerano L. Joint Bone Spine. 2019 Mar;86(2):129-130. doi: 10.1016/j.jbspin.2018.06.007
  • High prevalence of spondyloarthritis in sarcoidosis patients with chronic back pain.Sigaux J, Semerano L, Nasrallah T, Nunes H, Bouvry D, Valeyre D, Boissier MC, Saidenberg-Kermanac'h N. Semin Arthritis Rheum. 2019 Mar 11. pii: S0049-0172(18)30778-9.
  • Microenvironment tailors nTreg structure and function. Schiavon V, Duchez S, Branchtein M, How-Kit A, Cassius C, Daunay A, Shen Y, Dubanchet S, Colisson R, Vanneaux V, Pruvost A, Roucairol C, Setterblad N, Bouaziz JD, Boissier MC, Semerano L, Graux C, Bensussan A, Burny A, Gallo R, Zagury D, Le Buanec H. Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6298-6307
  • Neutrophil extracellular traps exert both pro- and anti-inflammatory actions in rheumatoid arthritis that are modulated by C1q and LL-37. Ribon M, Seninet S, Mussard J, Sebbag M, Clavel C, Serre G, Boissier MC, Semerano L, Decker P. J Autoimmun. 2019 Mar ;98:122-131.
  • MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease. Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, González-Pérez MI, Mejía M, Buendía-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Lioté H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clément A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieudé P. N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562.

2018

  • Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection.Belmellat N, Semerano L, Segueni N, Damotte D, Decker P, Ryffel B, Quesniaux V, Boissier MC, Assier E. Front Immunol. 2017 Nov 14;8:1533
  • Salt, inflammatory joint disease, and autoimmunity. Sigaux J, Semerano L, Favre G, Bessis N, Boissier MC. Joint Bone Spine. 2017 Jun 23. pii: S1297-319X(17)30129-X. doi: 10.1016/j.jbspin.2017.06.003.
  • Developments with experimental and investigational drugs for axial spondyloarthritis. Clavel G, Boissier MC, Sigaux J, Semerano L. Expert Opin Investig Drugs. 2017 Jul;26(7):833-842. doi: 10.1080/13543784.2017.1337744

2017

  • Do we need animal models to advance research on inflammatory joint disease? Boissier MC, Bessis N. Joint Bone Spine. 2017 Jul;84(4):381-383
  • Progressive multifocal leukoencephalopathy and rheumatoid arthritis treatments. Clavel G, Moulignier A, Semerano L. Joint Bone Spine. 2017 Dec;84(6):671-675. Doi : 10.1016/j.jbspin.2017.03.002. 2017 Mar 18.
  • Arthritis models: usefulness and interpretation. Bessis N, Decker P, Assier E, Semerano L, Boissier MC. Semin Immunopathol. 2017 Jun;39(4):469-486. doi: 10.1007/s00281-017-0622-4.
  • Nutrition and chronic inflammatory rheumatic disease. Semerano L, Julia C, Aitisha O, Boissier MC. Joint Bone Spine. 2017 Oct;84(5):547-552. doi: 10.1016/j.jbspin.2016.10.003.
  • Developments with experimental and investigational drugs for axial spondyloarthritis. Clavel G, Boissier MC, Sigaux J, Semerano L. Expert Opin Investig Drugs. 2017 Jul;26(7):833-842. doi: 10.1080/13543784.2017.1337744.
  • Vaccination Is Suitable for Treating Inflammatory Diseases. Assier E, Bessis N, Zagury JF, Boissier MC. Front Pharmacol. 2017 Jan 31;8:6. doi: 10.3389/fphar.2017.00006.
  • Vitamin D supplementation in patients treated for sarcoidosis: Controversy or consensus? Saidenberg-Kermanac'h N, Valeyre D, Boissier MC. Joint Bone Spine. 2017 Oct;84(5):521-523

2000- 2017

  • In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis. Biton J, Khaleghparast Athari S, Thiolat A, Santinon F, Lemeiter D, Hervé R, Delavallée L, Levescot A, Roga S, Decker P, Girard JP, Herbelin A, Boissier MC, Bessis N. J Immunol. 2016 Sep 1;197(5):1708-19. doi: 10.4049/jimmunol.1502124.
  • Developments with investigational Janus kinase inhibitors for rheumatoid arthritis. Semerano L, Decker P, Clavel G, Boissier MC. Expert Opin Investig Drugs. 2016 Dec;25(12):1355-1359.
  • Personality modulates proportions of CD4+ regulatory and effector T cells in response to socially induced stress in a rodent of wild origin. Rangassamy M, Khaleghparast Athari S, Monclús R, Boissier MC, Bessis N, Rödel HG. Physiol Behav. 2016 Dec 1;167:255-264. doi: 10.1016/j.physbeh.2016.09.016.
  • Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: A systematic literature review. Minichiello E, Semerano L, Boissier MC. Joint Bone Spine. 2016 Dec;83(6):625-630. doi: 10.1016/j.jbspin.2016.07.007.
  • Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33. Athari SK, Poirier E, Biton J, Semerano L, Hervé R, Raffaillac A, Lemeiter D, Herbelin A, Girard JP, Caux F, Boissier MC, Bessis N. Arthritis Res Ther. 2016 Jun 18;18(1):143. doi: 10.1186/s13075-016-1042-x.
  • Novel Immunotherapeutic Avenues for Rheumatoid Arthritis. Semerano L, Minichiello E, Bessis N, Boissier MC. Trends Mol Med. 2016 Mar;22(3):214-29. doi: 10.1016/j.molmed.2016.01.005. Review.
  • Aortic VCAM-1: an early marker of vascular inflammation in collagen-induced arthritis. Denys A, Clavel G, Lemeiter D, Schischmanoff O, Boissier MC, Semerano L. J Cell Mol Med. 2016 May;20(5):855-63. doi: 10.1111/jcmm.12790.
  • Calpains Released by T Lymphocytes Cleave TLR2 To Control IL-17 Expression. Perez J, Dansou B, Hervé R, Levi C, Tamouza H, Vandermeersch S, Demey-Thomas E, Haymann JP, Zafrani L, Klatzmann D, Boissier MC, Letavernier E, Baud L. J Immunol. 2016 Jan 1;196(1):168-81. doi: 10.4049/jimmunol.1500749.
  • Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis. Semerano L, Duvallet E, Belmellat N, Marival N, Schall N, Monteil M, Grouard-Vogel G, Bernier E, Lecouvey M, Hlawaty H, Muller S, Boissier MC, Assier E. Angiogenesis. 2016 Jan;19(1):39-52. doi: 10.1007/s10456-015-9487-0.
  • Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritisSemerano L, Duvallet E, Belmellat N, Marival N, Schall N, Monteil M, Grouard-Vogel G, Bernier E, Lecouvey M, Hlawaty H, Muller S, Boissier MC, Assier E. . Angiogenesis. 2015 Sep 29.
  • Cachexia and adiposity in rheumatoid arthritis. Relevance for disease management and clinical outcomes.Challal S, Minichiello E, Boissier MC, Semerano L.   Joint Bone Spine. 2015 Jul 13.
  • Metabolomics for rheumatic diseases: has the time come? Semerano L, Roméo PH, Boissier MC.   Ann Rheum Dis. 2015 Jul;74(7):1325-6
  • Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial. Durez P, Vandepapeliere P, Miranda P, Toncheva A, Berman A, Kehler T, Mociran E, Fautrel B, Mariette X, Dhellin O, Fanget B, Ouary S, Grouard-Vogel G, Boissier MC. PLoS One. 2014 Dec 17;9(12):e113465.
  • Interleukin-6 Receptor Blockade Enhances CD39+ Regulatory T Cell Development in Rheumatoid Arthritis and in Experimental Arthritis. Thiolat A, Semerano L, Pers YM, Biton J, Lemeiter D, Portales P, Quentin J, Jorgensen C, Decker P, Boissier MC, Louis-Plence P, Bessis N. Arthritis Rheumatol. 2014 Feb;66(2):273-83.
  • TLR9 independent interferon α production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoantigen.  Lindau D, Mussard J, Rabsteyn A, Ribon M, Kötter I, Igney A, Adema GJ, Boissier MC, Rammensee HG, Decker P. Ann Rheum Dis. 2013 Sep 7. doi: 10.1136/annrheumdis-2012-203041.
  • Primary blood neutrophils express a functional cell surface Toll-like receptor 9. Lindau D, Mussard J, Wagner BJ, Ribon M,Rönnefarth VM, Quettier M, Jelcic I, Boissier MC, Rammensee HG, Decker P. Eur J Immunol. 2013 Aug;43(8):2101-13.
  • Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels. Semerano L, Biton J, Delavallée L, Duvallet E, Assier E, Bessis N, Bernier E, Dhellin O, Grouard-Vogel G, Boissier MC   Clin Exp Immunol. 2013 Apr;172(1):54-62. doi: 10.1111/cei.12040
  • Nuclease A (Gbs0661), an extracellular nuclease of Streptococcus agalactiae, attacks the neutrophil extracellular traps and is needed for full virulence. Derré-Bobillot A, Cortes-Perez NG, Yamamoto Y, Kharrat P, Couvé E, Da Cunha V, Decker P, Boissier MC, Escartin F, Cesselin B, Langella P, Bermúdez-Humarán LG, Gaudu P.  Mol Microbiol. 2013 Aug;89(3):518-31.
  • The mouse dendritic cell marker CD11c is down-regulated upon cell activation through Toll-like receptor triggering. Singh-Jasuja H*, Thiolat A*, Ribon M, Boissier MC, Bessis N, Rammensee HG, Decker P.  Immunobiology. 2013 Jan;218(1):28-39.* equal contribution
  • Benchmarking biomedical publications worldwide. Boissier MC. Rheumatology (Oxford). 2013 May 10.
  • Screening for latent tuberculosis in anti-TNF-α candidate patients in a high tuberculosis incidence setting.  Saidenberg-Kermanac'h N, Semerano L, Naccache JM, Brauner M, Falgarone G, Dumont-Fischer D, Guillot X, Valeyre D, Boissier MC. Int J Tuberc Lung Dis. 2012 Oct;16(10):1307-14.
  • TNFα: activator or inhibitor of regulatory T cells?  Biton J, Boissier MC, Bessis N. Joint Bone Spine. 2012 Mar;79(2):119-23.
  • Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction. Boissier MC, Semerano L, Challal S, Saidenberg-Kermanac'h N, Falgarone G.  J Autoimmun. 2012 Sep;39(3):222-8.
  • Modulation of anti-tumor necrosis factor alpha (TNF-α) antibody secretion in mice immunized with TNF-α kinoid. Assier E, Semerano L, Duvallet E, Delavallée L, Bernier E, Laborie M, Grouard-Vogel G, Larcier P, Bessis N, Boissier MC. . Clin Vaccine Immunol. 2012 May;19(5):699-703.
  • Anti-cytokine vaccination: a new biotherapy of autoimmunity? Semerano L, Assier E, Boissier MC. Autoimmun Rev. 2012 Sep;11(11):785.
  • Adrenomedullin, a neuropeptide with immunoregulatory properties induces semi-mature tolerogenic dendritic cells. Rullé S, Ah Kioon MD, Asensio C, Mussard J, Ea HK, Boissier MC, Lioté F, Falgarone G.  Immunology. 2012 Jun;136(2):252-64
  • Active immunization against IL-23p19 improves experimental arthritis.Ratsimandresy RA, Duvallet E, Assier E, Semerano L, Delavallée L, Bessis N, Zagury JF, Boissier MC  Vaccine. 2011 Nov 21;29(50):9329-36
  • Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis. Biton J, Semerano L, Delavallée L, Lemeiter D, Laborie M, Grouard-Vogel G, Boissier MC, Bessis N. J Immunol. 2011 Apr 1;186:3899-910.
  • Kinoid of human tumor necrosis factor-alpha for rheumatoid arthritis. Semerano L, Assier E, Delavallée L, Boissier MC.  Expert Opin Biol Ther. 2011 Apr;11(4):545-50. Mar 9.
  • Neutrophils and interferon-a-producing cells: who produces interferon in lupus? Decker P.  Arthritis Res Ther, 2011, 13:118-20.
  • A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis.  Veenbergen S, Bennink MB, Affandi AJ, Bessis N, Biton J, Arntz OJ, van den Berg WB, van de Loo FA.  Ann Rheum Dis. 2011 Dec;70(12):2167-75.
  • Interleukin-23: A key cytokine in inflammatory diseases. Duvallet E, Semerano L, Assier E, Falgarone G, Boissier MC.  Ann Med. Ann Med. 2011 Nov;43(7):503-11.
  • Cell and cytokine imbalances in rheumatoid synovitis.  Boissier MC. Joint Bone Spine. 2011 ;78:230-4.
  • Interleukin-6: from identification of the cytokine to development of targeted treatments. Assier E, Boissier MC, Dayer JM.  Joint Bone Spine. 2010 ;77:532-6.
  • Blood vessels, a potential therapeutic target in rheumatoid arthritis? Semerano L, Clavel G, Assier E, Denys A, Boissier MC. Joint Bone Spine. 2011;78:118-23.
  • Intra-articular electrotransfer of mouse soluble tumour necrosis factor receptor in a murine model of rheumatoid arthritis. Denys A, Thiolat A, Descamps D, Lemeiter D, Benihoud K, Bessis N, Boissier MC J Gene Med. 2010;12:659-68.
  • Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment. Miellot-Gafsou A, Biton J, Bourgeois E, Herbelin A, Boissier MC, Bessis N. Immunology. 2010 ;130:296-306.
  • Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis. Delavallée L, Semerano L, Assier E, Vogel G, Vuagniaux G, Laborie M, Zagury D, Bessis N, Boissier MC.  Arthritis Res Ther. 2009;11(6):R195. Epub 2009 Dec 23.
  • Regulatory T cells (Treg) in rheumatoid arthritis. Boissier MC, Assier E, Biton J, Denys A, Falgarone G, Bessis N. Joint Bone Spine. 2009;76:10-4.
  • No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Jaen O, Petit-Teixeira E, Kirsten H, Ahnert P, Semerano L, Pierlot C, Cornelis F, Boissier MC, Falgarone G; European Consortium on Rheumatoid Arthritis Families.  Arthritis Res Ther. 2009;11:R5. Epub 2009 Jan 13.
  • Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo Jaen O, Rullé S, Bessis N, Zago A, Boissier MC, Falgarone G. . Immunology. 2009;126:35-44..
  • Budget impact model of rituximab after failure of one or more TNFalpha inhibitor therapies in the treatment of rheumatoid arthritis. Launois R, Payet S, Saidenberg-Kermanac'h N, Francesconi C, França LR, Boissier MC. Joint Bone Spine. 2008;75:688-95.
  • Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm.  Boissier MC, Assier E, Falgarone G, Bessis N. Joint Bone Spine. 2008;75:373-5.
  • ltrasound and Doppler micro-imaging in a model of rheumatoid arthritis in mice. Clavel G, Marchiol-Fournigault C, Renault G, Boissier MC, Fradelizi D, Bessis N. U Ann Rheum Dis. 2008 ;67:1765-72.
  • Emerging applications of anticytokine vaccines Delavallée L, Assier E, Semerano L, Bessis N, Boissier MC. . Expert Rev Vaccines. 2008;7:1507-17.
  • Vaccination with cytokines in autoimmune diseases. Delavallée L, Assier E, Denys A, Falgarone G, Zagury JF, Muller S, Bessis N, Boissier MC  Ann Med. 2008;40:343-51.
  • arly and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalpha. Delavallée L, Le Buanec H, Bessis N, Assier E, Denys A, Bizzini B, Zagury D, Boissier MC. E Ann Rheum Dis. 2008;67:1332-8.
  • synoviocytes infection by AAV is neutralized by human synovial fluid from arthritis patients and depends on AAV serotype. Boissier M-C, Lemeiter D., Valvason C Clavel G, Laroche L. , Begue T., and Bessis N. SHum Gene Ther, 2007 , 18 : 525-35.
  • Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clavel C, Bessis N, Fardellone P, Othmane M, Menard JF, Pouplin S, Boumier P, Vittecoq O, Le Loêt X, Boissier MC.  Clin Immunol,2007, 124: 158-64.
  • Kinoid vaccination-induced neutralizing antibodies to TNFα protects mice from autologous TNFα driven chronic and acute inflammation Le Buanec H*, Delavallée L*, Bessis N,  Paturance S, Bizzini B, Gallo R,  Zagury D, Boissier MC. TNFα (* same ctd). Proc Natl Acad Sci, 2006,103:19442-7
  • Improvement of collagen-induced arthritis by active immunization against murine IL-1 peptides designed by molecular modelling. Bertin-Maghit SM, Capini CJ , Bessis N, Chomilier J, Muller S, Abbas A, Regulier EG, Rappaport J, Therwath A, Zagury JF*, Boissier MC*.  Vaccine 2005, 23:4228-35 (* same cont.)
  • Practices for Managing a Flare of Long-Standing Rheumatoid Arthritis: Survey among French Rheumatologists Maravic M, Bergé C, Daurès JP, Boissier MC , Clin Exp Immunol, 2005,23:36-42
  • TNF-a antibodies and osteoprotegerin decrease systemic bonne loss-associated with inflammation through distinct mechanisms in collagen-induced arthritis. Saidenberg-Kermanac’h N, Corrado A, Lemeiter D, de Vernejoul MC, Boissier MC, Cohen-Solal M.  Bone, 2004, 35:1200-7
  • Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants. Bessis N*, Bloquel N*, Boissier MC, Scherman D, Bigey P. Hum Gene Ther 2004 ; 15 : 189-201
  • Effect of Synovial Fluid on Adeno-Associated Virus-Mediated Gene Transfer to Chondrocytes Cottard V, Valvasson C, Falgarone G, Lutomski D, Boissier MC, Bessis N  J Clin Immunol, 2004, 24 : 162-9
  • IgG reactivity with a 100 kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited abd diffuse systemic sclerosis patients. Garcia de la Pena-Lefebvre P, Chanseaud Y, Tamby MC, Reinbolt J, Batteux F, Allanore Y, Kahan A, Meyer O, Benveniste O, Boyer O, Guillevin L, Boissier MC, Mouthon L.  Clin Immunol 2004, 11:241-51
  • Survey of Practices Regarding Management of Early Typical Rheumatoid Arthritis by Rheumatologists in France. Maravic M, Bergé C, Daurès JP, Boissier MC , Clin Exp Rheumatol, 2004, 22:319-27
  • Osteoprotegerin and interleukin-4 cellular gene therapy decrease bone resorption-associated inflammation in collagen-induced arthritis Saidenberg-Kermanac’h N, Bessis N, Lemeiter D, de Vernejoul MC, Boissier MC, Cohen-Solal M. . J Clin Immunol, 2004, 24 :370-8
  • Efficacy of interleukin-10 gene electrotransfer into skelettal muscle in mice with collagen-induced arthritis. Saidenberg-Kermanac’h N, Bessis N, Deleuze V, Blocquel C, Bureau M, Scherman D,Boissier MC.  J Gene Med, 2003, 5; 164-71
  • Syngeneic fibroblasts engineered to secrete interleukin-4 as vectors for antiinflammatory gene therapy in collagen-induced arthritis. Bessis N, Cottard V, Saidenberg-Kermanac’h N, Lemeiter D, Fournier C, Boissier MC.  J Gene Med, 2002, 4 :300-7
  • Osteoprotegerin and inflammation. Saidenberg-Kermanac’h N, Bessis N, Cohen-Solal M, de Vernejoul M, Boissier MC.  Eur Cytokine Netw, 2002, 13 :144-53
  • Gene therapy for rheumatoid arthritis. Bessis N, Doucet C, Cottard V, Douar AM, Firat H, Jorgensen C, Mezzina M, Boissier MC  J Gene Med, 2002 ;4 :581-91
  • ardiac manifestations of rheumatoid arthritis : a case control transoesophageal echocardiography study in 30 patients. Guedes C, Bianchi-Fior P, Cormier B, Barthelemy B, Rat AC, Boissier MC. C Arthritis Rheum , 2001, 45:129-35.
  • Collagen II-pulsed antigen-presenting cells engineered to secrete IL-4 down regulate collagen-induced arthritis. Guéry L, Chiocchia G, Batteux F, Boissier MC C, Fournier C.  Gene Ther, 2001, 8 : 1855,62
  • Expression of fas ligand improves the therapeutic effect if IL-4 in collagen-induced arthritis Guéry L, Batteux F, Bessis N, Bréban M, Boissier MC, Fournier C, Chiocchia G. . Eur J Immunol, 2000;30:308-15
  • The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis. Bessis N, Guéry L, Mantovani A, Vecchi A, Sims J, Fradelizi D, Boissier MC.  Eur J Immunol,2000;30:867-75
  • Adeno-associated virus mediated delivery of IL-4 prevents collagen-induced arthritis. Cottard V, Mulleman Bouillé P, Mezzina M, Boissier MC, Bessis N.  Gene Ther, 2000; 7: 1930-9
 

Former publication of present members of Li2P

JEROME BITON

 • The new histological classification of lung primary adenocarcinoma subtype is a reliable prognostic marker and it identifies tumours with different mutation status: the experience of a French cohort. Mansuet-Lupo A, Bobbio A, Blons H, Becht E, Ouakrim H, Didelot A, Charpentier MC, Bain S, Marmey B, Bonjour P, Biton J, Cremer I, Dieu-Nosjean MC, Sautès-Fridman C, Régnard JF, Laurent-Puig P, Alifano M, Damotte D. Chest. 2014 Sep;146(3):633-43.
• Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer. Alifano M, Mansuet-Lupo A, Lococo F, Roche N, Bobbio A, Canny A, Schussler O, Dermine H, Régnard JF, Burroni B, Goc J, Biton J, Ouakrim H, Dieu-Nosjean MC, Cremer I and Damotte D. PLOS ONE. 2014 Sep 19;9(9):e106914.
• Calreticulin expression by non-small-cell lung cancer correlates with signs of immunosurveillance and favorable prognosis. J. Fucikova, E. Becht, K. Iribarren, J. Goc, R. Remark, D. Damotte, M. Alifano, P. Devi, J. Biton, C. Germain, W. H. Fridman, M-C. Dieu-Nosjean, G. Kroemer, C. Sautès-Fridman, I. Cremer. Cancer research. 2016 Apr 1;76(7):1746-56.
• Intra-tumoral immune cell densities are associated with lung adenocarcinoma gene alterations. Mansuet-Lupo A, Alifano M, Pécuchet N, Biton J, Becht E, Goc J, Germain C, Ouakrim H, Régnard JF, Cremer I, Laurent-Puig P, Dieu-Nosjean MC, Blons H, Damotte D. American Journal of Respiratory and Critical Care Medicine. 2016.
• Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients. R. Remark, A. Lupo, M. Alifano, J. Biton, H. Ouakrim, A. Stefani, I. Cremer, J. Goc, J-F Régnard, M-C Dieu-Nosjean and D. Damotte. Oncoimmunology. 2016 Dec 8; 5 (12).
• Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. E. Peranzoni, J. Lemoine, L. Vimeux, V. Feuillet, S. Barrin, C. Kantari, N. Bercovici, M. Guerin, J. Biton, H. Ouakrim, F. Regnier, A. Lupo, M. Alifano, D. Damotte, E.Donnadieu. Proceedings of the National Academy of Sciences. 2018 Apr 24;115(17):E4041-E4050.
• Impaired tumor-infiltrating T cells in patients with COPD impacts lung cancer response to PD-1 blockade. J. Biton, H. Ouakrim, A. Dechartres, M. Alifano, A. Mansuet-Lupo, H. Si, R. Halpin, T. Creasy, C. Bantsimba-Malanda, J. Arrondeau, F. Goldwasser, P. Boudou-Rouquette, L. Fournel, N. Roche, P-R. Burgel, J. Goc, P. Devi-Marulkar, C. Germain, M-C. Dieu-Nosjean, I. Cremer, R. Herbst, D. Damotte. American Journal of Respiratory and Critical Care Medicine. 2018 Oct 1;198(7):928-940.
• TP53, STK11 and EGFR Mutations Predict Tumor Immune Profile and the Response to anti-PD-1 in Lung Adenocarcinoma. J. Biton, A. Mansuet-Lupo, N. Pécuchet, M. Alifano, H. Ouakrim, J. Arrondeau, P. Boudou-Rouquette, F. Goldwasser, K. Leroy, J. Goc, C. Germain, P. Laurent-Puig, M-C. Dieu-Nosjean, I. Cremer, R. Herbst, H. Blons, D. Damotte. Clinical Cancer Research. 2018 Nov 15;24(22):5710-5723.
• Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome. V. M. Braud, J. Biton, E. Becht, S. Knockaert, A. Mansuet-Lupo, E. Cosson, D. Damotte, M. Alifano, P. Validire, F. Anjuère, I. Cremer, N. Girard, D. Gossot, A.Seguin-Givelet, M-C Dieu-Nosjean & C. Germain. Oncoimmunology. 2018 Dec 8; 5 (12).
• Proposal for a combined histo-molecular algorithm to distinguish multiple primary adenocarcinomas from intrapulmonary metastasis in patients with multiple lung tumors. A. Mansuet-Lupo, M. Barritault, M. Alifano, A Janet-Vendroux, M. Zarmaev, J. Biton, Y. Velut, C. Le Hay, I. Cremer2, J-F Régnard, L. Fournel, B. Rance, M. Wislez, P. Laurent-Puig, R. Herbst, D. Damotte, H. Blons. Journal of Thoracic Oncology. 2019 May;14(5):844-856.
• The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort. D. Damotte, S.Warren, J. Arrondeau, P. Boudou-Rouquette, A. Lupo, J. Biton, H. Ouakrim, M. Alifano, C. Gervais, A, Bellesoeur, N. Kramkimel, C. Tlemsani, B. Burroni, A. Duche, F. Letourneur, H. Si, R. Halpin, T. Creasy, R. Herbst, X. Ren, P. Morel, A. Cesano, F. Goldwasser, K. Leroy. Journal of Translational Medicine. 2019 Nov 4;17(1):357.
• Tertiary lymphoid structure-B cells narrow regulatory T cells impact in lung cancer patients. C. Germain, P. Devi-Marulkar, S. Knockaert, J. Biton, H. Kaplon, L. Letaïef, J. Goc, A Seguin-Givelet, D. Gossot, N. Girard, P. Validire, M. Lefevre, D. Damotte, M. Alifano, F. Lemoine, K. Steele, J-L. Teillaud, S. A. Hammond and MC. Dieu-Nosjean. Frontiers in Immunology. 2021 Mar 8;12:626776.
• SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils. Y. Velut, E. Decroix, H. Blons, M. Alifano, K. Leroy, F. Petitprez, A. Boni, S. Garinet, J. Biton, I. Cremer, M. Wislez, P. Boudou-Rouquette, J. Arrondeau, F. Goldwasser, L. Fournel, D. Damotte, A. Mansuet-Lupo. Lung cancer. 2022, 169, 13-21. 

ELODIE RIVIERE

  • Interleukin-7/Interferon axis drives T-cell and salivary gland epithelial cell interactions in Sjögren’s syndrome. E Rivière, J Pascaud, A Virone et al, Arthritis Rheumatol. 2021 ; 3(4):631-640
  • Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation. E Rivière, J Pascaud, N Tchitchek, et al., , Ann Rheum Dis. 2020 ; 79:1468-1477
  • Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. E Rivière1, J Sellam1, A Courties, et al., , Arthritis Res Ther. 2016 ; 18(1):294. 1equal contributors
  • Clinicopathological features of multiple mononeuropathy associated with systemic lupus erythematosus: a multicenter study. E Rivière, F Cohen Aubart, T Maisonobe, et al., Journal of Neurology, 2017;264(6):1218-1226
  • Restoration of default blood monocyte-derived macrophage polarization with adalimumab but not etanercept in rheumatoid arthritis. A Paoletti, B Ly, S Bitoun, G Nocturne, E Rivière, et al., Frontiers in Immunology, 2022 ; 23;13:832117
  • Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndrome. Dupré A, Pascaud J, Rivière E, et al., RMD Open. 2021; 7(1):e001442
  • Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors. A Paoletti, J Rohmer, B Ly, J Pascaud, E Rivière, R Seror, B Le Goff, G Nocturne, X Mariette, J Immunol, 2019 ; 1;203(7):1766-1775
  • Role of the IL-12/IL-35 balance in patients with Sjögren syndrome. Fogel O, Rivière E, Seror R, et al.,. J Allergy Clin Immunol. 2018 ; 142(1):258-268.e5

 

LEA PAOLINI

  • J-F Augusto†, C Beauvillain†, C Poli, L Paolini, I Tournier, P Pignon, S Blanchard, L Preisser, R Soleti, C Delépine, M Monnier, I Douchet, P Asfar, F Beloncle, O Guisset, R Prével, A Mercat, E Vinatier, J Goret, J-F Subra, D Couez, M R W, P Blanco, P Jeannin, Y Delneste, Clusterin Neutralizes the Inflammatory and Cytotoxic Properties of Extracellular Histones, Am J Respir Crit Care Med. 2023 May 4, PMID: 37141109
  • T Tran , J-R Lavillegrand, C Lereverend, B Esposito, L Cartier, M Montabord , J Tran-Rajau, M Diedisheim, N Gruel, K Ouguerram, L Paolini, O Lenoir, E Pinteaux, E Brabencova, C Tanchot, P Urquia, J Lehmann-Che, R Le Naour, Y Merrouche, C Stockmann, Z Mallat, A Tedgui, H Ait-Oufella, E Tartour , S Potteaux , Mild dyslipidemia accelerates tumorigenesis through expansion of Ly6Chi monocytes and differentiation to pro-angiogenic myeloid cells, Nature Communication. 2022;13(1):5399. PMID: 36104342
  • L Paolini†, C Adam†, N Gueguen†, G Mabilleau, L Preisser, S Blanchard, P Pignon, F Manero, M Le Mao, A Morel, P Renier, C Beauvillain, Y Delneste‡, V Procaccio‡, P Jeannin‡ Acetoacetate protects macrophages from lactic acidosis-induced mitochondrial dysfunction by metabolic reprograming Nature Communication 12, 7115 (2021) PMID: 34880237 
  • S Karaki †, C Blanc†, T Tran†, I Galy-Fauroux, A Mougel, E Dransart, M Anson, C Tanchot , L Paolini, N Gruel, L Gibault, F Lepimpec-Barhes, E Fabre, N Benhamouda, C Badoual, D Damotte, E Donnadieu, S Kobold, F Mami-Chouaib, R Golub, L Johannes, E Tartour, CXCR6 deficiency impairs cancer vaccine efficacy and CD8 + resident memory T-cell recruitment in head and neck and lung tumors, J journal for Immunotherapy of Cancer. 2021 Mar;9(3):e001948 PMID: 33692218
  • L Paolini†, C Adam†, C Beauvillain, L Preisser, S Blanchard, P Pignon, V Seegers, L-M Chevalier, M Campone, R Wernert, V Verriele, P Raro, N Ifrah, V Lavoue, P Descamps, Morel, V Catros, G Tcherkez, G Lenaers, C Bocca, J Kouassi Nzoughet, V Procaccio, Y Delneste and P Jeannin. Lactic acidosis together with GM-CSF and M-CSF induces human macrophages toward an inflammatory pro-tumor phenotype. Cancer Immunology Research. 2020 Jan 10. pii: canimm.0749.201. PMID 31924656
  • L Paolini, C Poli, S Blanchard, T Urban, A Croué, M-Ch Rousselet, S Le Roux, N Labarrière, P Jeannin, J Hureaux. Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatment, Journal for Immunotherapy of Cancer. 2018 Jun 13;6(1):52 , PMID 29898781
  • C Rabu, L Rangan, L Florenceau, A Fortun, M Charpentier, E Dupré, L Paolini, C Beauvillain, E Dupel, J-B Latouche, O Adotevi, N Labarrière & F Lang. Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells. 2019 Jan 17;8(4):e1560919. , PMID: 30906653

Revues

  • L Paolini†, M Monnier†, E Vinatier, A Mantovani, Y Delneste and P Jeannin et al, Antitumor strategies targeting macrophages: the importance of considering the differences in differentiation/polarization processes between human and mouse macrophages, Journal for ImmunoTherapy of Cancer 2022;10:e005560. PMID:36270732
  • L Paolini, A Saldmann, E Tartour, Lymphocytes T-CD8 et immunothérapie anti-tumorale: rôle et ciblage thérapeutique. Bulletin de l'Académie Nationale de Médecine, Volume 205, Issue 4, 2021, Pages 354-363, DOI : 10.1016/j.banm.2021.01.018
  • E De Guillebon, A Dardenne, A Saldmann, S Séguier, T Tran, L Paolini, C Lebbe, E Tartour, Beyond the Concept of Cold and Hot Tumors for the Development of Novel Predictive Biomarkers and the Rational Design of Immunotherapy Combination, Internation Journal of Cancer, 2020 Jan 30. doi: 10.1002/ijc.32889 , PMID: 31997345
  • P Jeannin, L Paolini, C Adam, Y Delneste. The roles of CSFs on the functional polarization of tumor- associated macrophages. FEBS J. 2018 Feb;285(4):680-699 , PMID 29171156

 

PATRICE DECKER

  • Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus. Lindau D, Rönnefarth V, Erbacher A, Rammensee HG, Decker P. Eur J Immunol, 2011, 41:669-81.
  • Antineuronal antibodies in sporadic late-onset cerebellar ataxia. Bürk K, Wick M, Roth G, Decker P, Voltz, R.  J Neurol, 2010, 257:59-62.
  • Neurological symptoms in patients with biopsy proven celiac disease. Bürk K, Farecki ML, Lamprecht G, Roth G, Decker P, Weller M, Rammensee HG, Oertel WHO. Mov Disord, 2009, 24:2358-62.
  • Neutrophils, dendritic cells and chromatin-mediated pathogenesis in systemic lupus erythematosus. Lindau D, Decker P.  Autoimmunity, 2009, 42:254-6.
  • Chromatin modifications, oxidative stress and nucleosome autoantibodies. In: The epigenetics of autoimmune diseases. Erbacher A, Decker P.  2009, 119-34. Editor, Moncef Zouali; Publisher, Wiley Inc., New York.
  • Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. Kloss M*, Decker P*, Baltz K, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih H.  J Immunol, 2008, 181: 6711-19. *The first two authors contributed equally to this work.
  • The PDE4 inhibitor rolipram prevents NF-kappaB binding activity and proinflammatory cytokine release in human chorionic cells. Hervé R, Schmitz T, Evain-Brion D, Cabrol D, Leroy MJ, Méhats C. J Immunol. 2008 Aug 1;181(3):2196-202.
  • Circulating nucleosomes due to a defective clearance of dying cells: consequences in systemic lupus erythematosus. Erbacher A, Rönnefarth V, Decker P.  Autoimmunity, 2007, 40:311-14.
  • Heteroclitic properties of mixed a- and aza-b3-peptides mimicking a supradominant CD4 T cell epitope presented by nucleosome. Dali H, Busnel O, Hoebeke J, Bi L, Decker P, Briand JP, Baudy-Floc’h M, Muller S.  Mol Immunol, 2007, 44:3024-36.
  • TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus. Rönnefarth V, Erbacher A, Lamkemeyer T, Madlung J, Nordheim A, Rammensee HG, Decker P. J Immunol, 2006, 177:7740-9.
  • Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Decker P, Kötter I, Klein R, Berner B, Rammensee HG.  Rheumatology, 2006, 45:1087-95.
  • Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. Decker P, Singh-Jasuja H, Haager S, Kötter I, Rammensee HG.  J Immunol, 2005, 174:3326-34.
  • Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectromotry. Dengjel J*, Decker P*, Schoor O, Altenberend F, Weinschenk T, Rammensee HG, Stevanovic S. Eur J Immunol, 2004, 34:3644-51. *The first two authors contributed equally to this work.
  • Nucleosomes induce lymphocyte necrosis. Decker P, Wolburg H, Rammensee HG.  Eur J Immunol, 2003, 33:1978-87.
  • Detection of nucleosome particles in the sera of patients with SLE using monoclonal antibody 4H7. Williams RC, Malone CC, Meyers C, Decker P, Muller S.  J Rheumatol, 2001, 28:81-94.
  • Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis. Decker P, Isenberg DA, Muller S.  J Biol Chem, 2000, 275:9043-6.
  • Molecular and structural properties of three autoimmune IgG monoclonal antibodies to histone H2B. Monestier M, Decker P, Briand JP, Gabriel JL, Muller S.  J Biol Chem, 2000, 275:13558-63.
  • Identification of a minimal T cell epitope recognised by anti-nucleosome Th cells in the C-terminal region of histone H4. Decker P, Le Moal A, Briand JP, Muller S.  J Immunol, 2000, 165:654-62.

 

Decker P, Le Moal A, Briand JP, Muller S.  J Immunol, 2000, 165:654-62.

USPN Campus de Bobigny

tour illustration bobigny

web li2p V3

-->